Screener
Precigen PGEN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Precigen in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValueOutstanding.
The source filing: Precigen’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356090-26-000017
| (Amounts in thousands, except share data) | March 31,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 118,392 | 134,594 |
| Commitments and contingencies (Note 14) | ||
| Shareholders' equity | ||
| Common stock, no par value, 700,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 355,903,977 shares and 353,910,926 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. | — | — |
| Additional paid-in capital | 2,369,529 | 2,362,252 |
| Accumulated deficit | (2,349,277) | (2,341,348) |
| Accumulated other comprehensive (loss) income | (17) | 7 |
| Total shareholders' equity | 20,235 | 20,911 |
Item 1. Condensed Consolidated Financial Statements
FAQ
- What is Precigen's common stock?
- Precigen (PGEN) reported common stock of $0 in Q1 2026.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Precigen's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude